ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004

Step By Step: New Tenure Track, Appointments Process

August 5, 1994

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008